Endothelial nitric oxide synthase genotypes modulate peripheral vasodilatory properties after myocardial infarction

Gene

Volumn 568, Issue 2, 2015, Pages 165-169

  Machado Silva, Wilcelly ^a   Alfinito Kreis, Rossana ^a   Carvalho, Luiz Sérgio F ^a   Quinaglia e Silva, José C ^b   Almeida, Osório L R ^b   Brito, Ciro J ^c   Ferreira, Aparecido P ^d   Córdova, Cláudio ^c   Sposito, Andrei C ^a,e   Nóbrega, Otávio T ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b HOSPITAL DE BASE DO DISTRITO FEDERAL   (Brazil)

^c UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

^d Interdisciplinary Research Nucleus of ICESP   (Brazil)

^e UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Myocardial infarction; Nitric oxide; Polymorphism; Vascular endothelium; Vasodilation

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN;

ACUTE HEART INFARCTION; ADULT; ALLELE; ARTICLE; BLOOD FLOW; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE PREDISPOSITION; DYSLIPIDEMIA; ENZYME BLOOD LEVEL; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPEREMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SMOKING; ST SEGMENT ELEVATION; VASODILATATION; AGED; CONVALESCENCE; ENZYMOLOGY; GENETIC ASSOCIATION; GENETICS; HEART INFARCTION; PATHOPHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOVERY OF FUNCTION; VASODILATION;

EID: 84930819101     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.05.042     Document Type: Article

References (43)

1. ADA (American Diabetes Association) Diagnosis and classification of diabetes mellitus. Diabetes Care 2005, 28(Suppl. 1):S37-S42.
2. Andrikopoulos G.K., Grammatopoulos D.K., Tzeis S.E., Zervou S.I., Richter D.J., Zairis M.N., Gialafos E.J., Sakellariou D.C., Foussas S.G., Manolis A.S., Stefanadis C.I., Toutouzas P.K., Hillhouse E.W., investigators, G.s. Association of the 894G>T polymorphism in the endothelial nitric oxide synthase gene with risk of acute myocardial infarction. BMC Med. Genet. 2008, 9:43.
3. Backinger C.L., Lawrence D., Swan J., Winn D.M., Breen N., Hartman A., Grana R., Tran D., Farrell S. Using the National Health Interview Survey to understand and address the impact of tobacco in the United States: past perspectives and future considerations. Epidemiol. Perspect. Innov. 2008, 5:8.
4. Baena C.P., Olandoski M., Luhm K.R., Costantini C.O., Guarita-Souza L.C., Faria-Neto J.R. Tendência de mortalidade por infarto agudo do miocárdio em Curitiba (PR) no período de 1998 a 2009. Arq. Bras. Cardiol. 2012, 98:211-217.
5. Baena C.P., Chowdhury R., Schio N.A., Sabbag A.E., Guarita-Souza L.C., Olandoski M., Franco O.H., Faria-Neto J.R. Ischaemic heart disease deaths in Brazil: current trends, regional disparities and future projections. Heart 2013, 99:1359-1364.
6. Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler. Thromb. Vasc. Biol. 2003, 23:168-175.
7. Casas J.P., Bautista L.E., Humphries S.E., Hingorani A.D. Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 2004, 109:1359-1365.
8. Chen W., Srinivasan S.R., Bond M.G., Tang R., Urbina E.M., Li S., Boerwinkle E., Berenson G.S. Nitric oxide synthase gene polymorphism (G894T) influences arterial stiffness in adults: the Bogalusa Heart Study. Am. J. Hypertens. 2004, 17:553-559.
9. Chu S.C., Marks-Konczalik J., Wu H.P., Banks T.C., Moss J. Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem. Biophys. Res. Commun. 1998, 248:871-878.
10. Corretti M.C., Anderson T.J., Benjamin E.J., Celermajer D., Charbonneau F., Creager M.A., Deanfield J., Drexler H., Gerhard-Herman M., Herrington D., Vallance P., Vita J., Vogel R., International Brachial Artery Reactivity Task, F. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J. Am. Coll. Cardiol. 2002, 39:257-265.
11. DHHS (Department of Health and Human Services) Physical Activity Guidelines Advisory Committee report, 2008. To the Secretary of Health and Human Services. Part A: executive summary. Nutr. Rev. 2009, 67:114-120.
12. Dias R.G., Alves M.J., Pereira A.C., Rondon M.U., Dos Santos M.R., Krieger J.E., Krieger M.H., Negrao C.E. Glu298Asp eNOS gene polymorphism causes attenuation in nonexercising muscle vasodilatation. Physiol. Genomics 2009, 37:99-107.
13. Dietz N.M., Engelke K.A., Samuel T.T., Fix R.T., Joyner M.J. Evidence for nitric oxide-mediated sympathetic forearm vasodilatation in humans. J. Physiol. 1997, 498(Pt 2):531-540.
14. Dipple K.M., McCabe E.R. Phenotypes of patients with "simple" Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics. Am. J. Hum. Genet. 2000, 66:1729-1735.
15. Dissmann R., Linderer T., Schroder R. Estimation of enzymatic infarct size: direct comparison of the marker enzymes creatine kinase and alpha-hydroxybutyrate dehydrogenase. Am. Heart J. 1998, 135:1-9.
16. Fabi F., Argiolas L., Chiavarelli M., Del Basso P. Nitric oxide-dependent and -independent modulation of sympathetic vasoconstriction in the human saphenous vein. Eur. J. Pharmacol. 1996, 309:41-50.
17. Grande P., Christiansen C., Alstrup K. Comparison of ASAT, CK, CK-MB, and LD for the estimation of acute myocardial infarct size in man. Clin. Chim. Acta 1983, 128:329-335.
18. Hingorani A.D., Liang C.F., Fatibene J., Lyon A., Monteith S., Parsons A., Haydock S., Hopper R.V., Stephens N.G., O'Shaughnessy K.M., Brown M.J. A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999, 100:1515-1520.
19. Horie M., Yasue H., Omote S., Takizawa A., Nagao M., Nishida S., Kubota J. A new approach for the enzymatic estimation of infarct size: serum peak creatine kinase and time to peak creatine kinase activity. Am. J. Cardiol. 1986, 57:76-81.
20. Joshi M.S., Mineo C., Shaul P.W., Bauer J.A. Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear. FASEB J. 2007, 21:2655-2663.
21. Ladeira R.T., Baracioli L.M., Faulin T.E., Abdalla D.S., Seydell T.M., Maranhao R.C., Mendonca B.B., Strunz C.C., Castro I.D., Nicolau J.C. Unrecognized diabetes and myocardial necrosis: predictors of hyperglycemia in myocardial infarction. Arq. Bras. Cardiol. 2013, 100:404-411.
22. Liu Y., Lu X., Xiang F.L., Poelmann R.E., Gittenberger-de Groot A.C., Robbins J., Feng Q. Nitric oxide synthase-3 deficiency results in hypoplastic coronary arteries and postnatal myocardial infarction. Eur. Heart J. 2014, 35:920-931.
23. Luo J.Q., Wen J.G., Zhou H.H., Chen X.P., Zhang W. Endothelial nitric oxide synthase gene G894T polymorphism and myocardial infarction: a meta-analysis of 34 studies involving 21,068 subjects. PLoS One 2014, 9:e87196.
24. Ma Y., Li L., Shang X.M., Tan Z., Geng X.B., Zhao B.Q., Tian M.R. Analysis of factors related to short-term prognosis in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Exp. Ther. Med. 2013, 5:1206-1210.
25. McDonald D.M., Alp N.J., Channon K.M. Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells. Pharmacogenetics 2004, 14:831-839.
26. Nawaz S.K., Rani A., Yousaf M., Noreen A., Arshad M. Genetic etiology of coronary artery disease considering NOS 3 gene variant rs1799983. Vascular 2015, 23:270-276.
27. Nordlander R., Nyquist O., Sylven C. Estimation of infarct size by creatine kinase. A comparison between maximal value, planimetry and computer calculation. Cardiology 1981, 68:201-205.
28. Otani H. The role of nitric oxide in myocardial repair and remodeling. Antioxid. Redox Signal. 2009, 11:1913-1928.
29. Passeri J., Bloch K.D. Nitric oxide and cardiac remodeling. Heart Fail. Clin. 2005, 1:275-286.
30. Philip I., Plantefeve G., Vuillaumier-Barrot S., Vicaut E., LeMarie C., Henrion D., Poirier O., Levy B.I., Desmonts J.M., Durand G., Benessiano J. G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation 1999, 99:3096-3098.
31. Pulkkinen A., Viitanen L., Kareinen A., Lehto S., Vauhkonen I., Laakso M. Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease. J. Mol. Med. (Berl.) 2000, 78:372-379.
32. Saraiva R.M., Minhas K.M., Raju S.V., Barouch L.A., Pitz E., Schuleri K.H., Vandegaer K., Li D., Hare J.M. Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium. Circulation 2005, 112:3415-3422.
33. Schulz E., Jansen T., Wenzel P., Daiber A., Munzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid. Redox Signal. 2008, 10:1115-1126.
34. Smith R.S., Agata J., Xia C.F., Chao L., Chao J. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sci. 2005, 76:2457-2471.
35. Soares J.d.S., Souza N.R.M.d., Nogueira Filho J., Cunha C.C., Ribeiro G.S., Peixoto R.S., Soares C.E.C., Soares L.C., Reis A.F., Faria C.A.C.d. Tratamento de uma coorte de pacientes com infarto agudo do miocárdio com supradesnivelamento do segmento ST. Arq. Bras. Cardiol. 2009, 92:464-471.
36. Strijdom H., Chamane N., Lochner A. Nitric oxide in the cardiovascular system: a simple molecule with complex actions. Cardiovasc. J. Afr. 2009, 20:303-310.
37. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol. Rev. 1999, 79:215-262.
38. Tesauro M., Thompson W.C., Rogliani P., Qi L., Chaudhary P.P., Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:2832-2835.
39. Veldman B.A., Spiering W., Doevendans P.A., Vervoort G., Kroon A.A., de Leeuw P.W., Smits P. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J. Hypertens. 2002, 20:2023-2027.
40. Wang X.L., Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol. Genet. Metab. 2000, 70:241-251.
41. WHO (World Health Organization) The World Health Statistics 2014. World Health Report 2014.
42. Zigra A.M., Rallidis L.S., Anastasiou G., Merkouri E., Gialeraki A. eNOS gene variants and the risk of premature myocardial infarction. Dis. Markers 2013, 34:431-436.
43. Ziolo M.T., Kohr M.J., Wang H. Nitric oxide signaling and the regulation of myocardial function. J. Mol. Cell. Cardiol. 2008, 45:625-632.